F-Star Therapeutics Inc (FSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 0 | 2,917 | 163 | 9,195 | 543 |
| Gross Profit | N/A | 2,917 | 163 | 9,195 | 543 |
| Operating Expenses | 14,792 | 13,561 | 9,141 | 12,582 | 5,329 |
| Operating Income | -14,792 | -10,644 | -8,978 | -3,387 | -4,786 |
| Interest Expense | 110 | 87 | 0 | 0 | 0 |
| Other Income | -515 | 1,105 | 259 | 60 | -1,641 |
| Pre-tax Income | -15,417 | -9,626 | -8,719 | -3,327 | -6,427 |
| Income Tax | 82 | 108 | -172 | 124 | 35 |
| Net Income Continuous | -15,499 | -9,734 | -8,547 | -3,451 | -6,462 |
| Net Income | $-15,499 | $-9,734 | $-8,547 | $-3,451 | $-6,462 |
| EPS Basic Total Ops | -0.91 | -1.07 | -0.36 | -1.88 | -3.53 |
| EPS Basic Continuous Ops | -0.91 | -1.07 | -0.36 | -1.88 | -3.53 |
| EPS Diluted Total Ops | -0.91 | -1.07 | -0.36 | -1.88 | -3.53 |
| EPS Diluted Continuous Ops | -0.91 | -1.07 | -0.36 | -1.88 | -3.53 |
| EPS Diluted Before Non-Recurring Items | -0.92 | -1.08 | N/A | N/A | N/A |
| EBITDA(a) | $-14,716 | $-10,423 | $-8,721 | $-2,834 | $-4,632 |